Myriad Genetics (MYGN) PT Lowered to $4 at TD Cowen
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $3.19 --0%
Rating Summary:
6 Buy, 19 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 24 | Down: 23 | New: 32
Rating Summary:
6 Buy, 19 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 24 | Down: 23 | New: 32
Join SI Premium – FREE
TD Cowen analyst Kyle Boucher lowered the price target on Myriad Genetics (NASDAQ: MYGN) to $4.00 (from $6.00) while maintaining a Hold rating.
You May Also Be Interested In
- JPMorgan Upgrades Telekom Malaysia Bhd (T:MK) (MYTEF) to Neutral
- Man Wah Holdings Limited (1999:HK) (MAWHF) PT Lowered to HK$3.50 at Goldman Sachs
- Bili (9626:HK) (BILI) PT Lowered to HK$170 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
